News & Insights
Sort By
Client News 10 Results
Client News
|August 6, 2026
Tarsus Pharmaceuticals to Acquire Alkeus Pharmaceuticals
Tarsus Pharmaceuticals announces its definitive agreement to acquire Alkeus Pharmaceuticals, a privately held retinal disease-focused biotechnology company developing gildeuretinol (ALK-001), an investigational once-daily oral therapy for Stargardt disease.
Client News
|June 30, 2026
Gunderson Dettmer Represents WideField Security in Agreement to be Acquired by Cisco
Gunderson Dettmer represented WideField Security in its agreement to be acquired by Cisco.
Client News
|December 4, 2025
Gunderson Dettmer Represented Hims & Hers in Acquisition of Livewell
Hims & Hers, the leading health and wellness platform, announces the acquisition of Livewell, a Canadian digital health platform